BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ying GS, Bell EF, Donohue P, Tomlinson LA, Binenbaum G; G-ROP Research Group. Perinatal Risk Factors for the Retinopathy of Prematurity in Postnatal Growth and Rop Study. Ophthalmic Epidemiol 2019;26:270-8. [PMID: 31012360 DOI: 10.1080/09286586.2019.1606259] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu YL, Ying GS, Quinn GE, Zhou XH, Chen Y. Extending Hui-Walter framework to correlated outcomes with application to diagnosis tests of an eye disease among premature infants. Stat Med 2021. [PMID: 34859902 DOI: 10.1002/sim.9269] [Reference Citation Analysis]
2 He Y, Pettenkofer M, Nittala MG, Sadda SR, Tsui I, Chu A. Early Postnatal Oxygen Exposure Predicts Choroidal Thinning in Neonates. Invest Ophthalmol Vis Sci 2021;62:23. [PMID: 34269816 DOI: 10.1167/iovs.62.9.23] [Reference Citation Analysis]
3 Zeng Y, Ge G, Lei C, Zhang M. Beyond Fetal Immunity: A Systematic Review and Meta-Analysis of the Association Between Antenatal Corticosteroids and Retinopathy of Prematurity. Front Pharmacol 2022;13:759742. [DOI: 10.3389/fphar.2022.759742] [Reference Citation Analysis]
4 Caruggi S, Scaramuzzi M, Calevo MG, Priolo E, Sposetti L, Camicione P, Ramenghi LA, Serafino M. Validation of the postnatal growth and retinopathy of prematurity screening criteria: A retrospective Italian analysis. Eur J Ophthalmol 2021;:11206721211011362. [PMID: 33887976 DOI: 10.1177/11206721211011362] [Reference Citation Analysis]
5 Graziosi A, Perrotta M, Russo D, Gasparroni G, D'Egidio C, Marinelli B, Di Marzio G, Falconio G, Mastropasqua L, Li Volti G, Mangifesta R, Gazzolo D. Oxidative Stress Markers and the Retinopathy of Prematurity. J Clin Med 2020;9:E2711. [PMID: 32825796 DOI: 10.3390/jcm9092711] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
6 Karmouta R, Altendahl M, Romero T, Piersante T, Langston S, Khitri M, Kading J, Tsui I, Chu A. Association Between Social Determinants of Health and Retinopathy of Prematurity Outcomes. JAMA Ophthalmol 2022. [PMID: 35420651 DOI: 10.1001/jamaophthalmol.2022.0667] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 de Alba Campomanes AG. Bridging the Gap-Untangling Race, Ethnicity, and Social Determinants of Health as Risk Factors for Retinopathy of Prematurity. JAMA Ophthalmol 2022. [PMID: 35420652 DOI: 10.1001/jamaophthalmol.2022.0668] [Reference Citation Analysis]
8 Yu Y, Tomlinson LA, Binenbaum G, Ying GS; G-Rop Study Group. Incidence, timing and risk factors of type 1 retinopathy of prematurity in a North American cohort. Br J Ophthalmol 2021;105:1724-30. [PMID: 32980817 DOI: 10.1136/bjophthalmol-2020-317467] [Reference Citation Analysis]
9 Pivodic A, E.h. Smith L, Hård A, Löfqvist C, Almeida AC, Al-hawasi A, Larsson E, Lundgren P, Sunnqvist B, Tornqvist K, Wallin A, Holmstrom G, Gränse L. Validation of DIGIROP models and decision support tool for prediction of treatment for retinopathy of prematurity on a contemporary Swedish cohort. Br J Ophthalmol. [DOI: 10.1136/bjophthalmol-2021-320738] [Reference Citation Analysis]
10 Mayock DE, Xie Z, Comstock BA, Heagerty PJ, Juul SE; Preterm Epo Neuroprotection (PENUT) Trial Consortium. High-Dose Erythropoietin in Extremely Low Gestational Age Neonates Does Not Alter Risk of Retinopathy of Prematurity. Neonatology 2020;117:650-7. [PMID: 33113526 DOI: 10.1159/000511262] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]